WATERTOWN, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (VIGL) (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the ...
A big federal research project aimed at reducing racial disparities in genetic research has unveiled the program's first major trove of results. "This is a huge deal," says Dr. Joshua Denny, who runs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback